Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary ...

The global preeclampsia drug market is poised for significant growth due to increasing awareness, advancements in diagnostics, and a higher prevalence of hypertension in pregnant women. Preeclampsia, ...

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 17th: ProKidney Corp. PROK: This clinical-stage biotechnology company has a Zacks Rank #1 ...

Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary (unaudited) financial results for the second ...

List today: Pharming Group N.V. PHAR: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing nearly 7% over the last 60 days. Pharming Group N.V.

The latest Pharming Group NV American Depositary Shares Repr 10 Shs Reg S stock prices, stock quotes, news, and PHAR history to help you invest and trade smarter.

A teenager who lost her mother, aunt and uncle to a genetic condition has become the first person in Europe to receive a ...

Access AS:PHAR financials, view the annual report and financial statements, including income statement, balance sheet, cash flow.

(Reuters) -KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral treatment for a type of hereditary swelling disorder, sending ...

KalVista Pharma has finally received FDA approval for its oral kallikrein inhibitor sebetralstat, becoming the first ...

Breakthrough for teen who lost four family members to inherited condition Mary Catchpole, 19, has the same life-threatening genetic condition, activated PI3-Kinase delta syndrome (APDS) ...